DalsnaFinance › IPOs › Spero Therapeutics › IPO
Spero Therapeutics, Inc. completed its initial public offering on NASDAQ on November 2, 2017, pricing at $14.00 a share.
| Ticker | SPRO |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | November 2, 2017 |
| Offering price | $14.00 |
| Shares offered | 5,500,000 |
| Total raised | $77M |
Spero Therapeutics, Inc. sold 5,500,000 shares at $14.00 each on NASDAQ. Multiplied out, that is $77 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $77 million total recorded for the deal.
Spero Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Spero Therapeutics, Inc.. This page is general information, not investment advice.